In FocusComparison of three‐factor and four‐factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers
Under an Elsevier user license
open archive
Keywords
anticoagulants
hemorrhage
pharmacology
prothrombin complex concentrates
rivaroxaban
Cited by (0)
See also Makris M. Prothrombin complex concentrate for non‐vitamin K oral anticoagulant reversal: good enough for now? J Thromb Haemost 2014; DOI: 10.1111/jth.12667
Manuscript handled by: S. Kitchen
Final decision: F. R. Rosendaal, 30 April 2014
Clinical Trial Registration: www.ClinicalTrials.gov NCT01656330
Copyright © 2014 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.